LAB FARMACEUT ERFO

Research LAB FARMACEUT ERFO (ERFO.MI) on Bullrun: market cap EUR 9.61M, P/E 28.5. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 9.61M; P/E is 28.5.

Peer valuation comparison

Latest P/E is 28.5x versus a Consumer Defensive sector median of 17.41x (63.7% above).

Latest P/E is 28.5x versus a Italy median of 17.69x (61.2% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025EUR 9.66MEUR 381.62K-EUR 1.65M69.6%0.04EUR 1.05MEUR 1.35MEUR 7.96M
FY2024n/aEUR 366.98KEUR 723.00Kn/a0.04n/an/an/a
FY2023EUR 5.93MEUR 553.82K-EUR 148.29K43.8%0.07EUR 843.44Kn/aEUR 7.86M
FY2022EUR 4.72MEUR 716.07K-EUR 416.06K72.0%0.08EUR 1.47MEUR 581.09KEUR 3.47M
FY2021EUR 4.82Mn/an/a71.6%n/aEUR 347.00KEUR 742.00KEUR 4.73M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-15EUR 9.61M28.5n/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 EUR.

YearDividends/share
FY20240.06 EUR

About LAB FARMACEUT ERFO

Laboratorio Farmaceutico Erfo S.p.A. engages in the developing and production of food supplements in Italy. It provides therapeutic solutions for andrology, gastroenterology, gynecology, neurology, dentistry, orthopedics, and vascular therapeutic areas. Laboratorio Farmaceutico Erfo S.p.A. was founded in 2013 and is based in Villafranca Tirrena, Italy.

Related stock research

Other Consumer Defensive stocks

Frequently asked questions

What is LAB FARMACEUT ERFO's market cap?

LAB FARMACEUT ERFO's market capitalization is EUR 9.61M.

What is LAB FARMACEUT ERFO's P/E ratio?

LAB FARMACEUT ERFO's price-to-earnings (P/E) ratio is 28.5.

What does LAB FARMACEUT ERFO do?

Laboratorio Farmaceutico Erfo S.p.A. engages in the developing and production of food supplements in Italy. It provides therapeutic solutions for andrology, gastroenterology, gynecology, neurology, dentistry, orthopedics, and vascular therapeutic areas. Laboratorio Farmaceutico Erfo S.p.A. was founded in 2013 and is based in Villafranca Tirrena, Italy.